Use of rHuG-CSF in New Chemotherapy Strategies
Reference94 articles.
1. Crawford J, Ozer H, Stoller R et al (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164–70
2. Trillet-Lenoir V, Green J, Manegold C et al (1993) Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29A:319–24
3. Renwick W, Pettengall R, Green M (2009) The use of filgrastim for supporting chemotherapy delivery: two decades of experience. Biodrugs 23:175–186
4. Citron M, Berry D, Cirrincione C et al (2003) Randomized trial of dose-dense versus conventially scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21:1431–1439
5. Druker B, Tamara S, Buchdunger E et al (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561–566